Sinovant has a diverse pipeline aiming to solve the unmet clinical needs in China. The product spanning over 8 therapeutic areas including oncology, infectious disease, urology, metabolic disease, pulmonary disease, gastroenterology, dermatology and rare diseases. Among the 13 drug candidates, 2 drugs are approved overseas. Selected ongoing clinical trials in China are as below:

Product SNV001(Lefamulin)
Indication Community-Acquired Bacterial Pneumonia (CABP)
Study Title A Clinical Study to Evaluate Pharmacokinetics, Safety and Tolerance of Single and Multiple Doses of Lefamulin in Chinese Healthy Subjects

Clinical Trial Details

Product SNV001(Lefamulin)
Indication Community-Acquired Bacterial Pneumonia (CABP)
Study Title A Clinical Study to Compare the Efficacy and Safety of Lefamulin Versus Moxifloxacin in Chinese Adults with Community-Acquired Bacterial Pneumonia

Clinical Trial Details

Product SNV002(Derazantinib)
Indication Intrahepatic Cholangiocarcinoma (iCCA)
Study Title A Clinical Study to Evaluate Safety and Efficacy of ARQ 087 in Chinese Inoperable, Recurrent or Metastatic Intrahepatic Cholangiocarcinoma Subjects with Advanced Solid Tumors and FGFR2 Gene Fusion Positive Who Failed at Least First-Line Systemic Therapy

Clinical Trial Details

Sinovant has a diverse pipeline aiming to solve the unmet clinical needs in China. The product spanning over 8 therapeutic areas including oncology, infectious disease, urology, metabolic disease, pulmonary disease, gastroenterology, dermatology and rare diseases. Among the 13 drug candidates, 2 drugs are approved overseas. Selected ongoing clinical trials in China are as below:
Product Indication Study Title
SNV001(Lefamulin) Community-Acquired Bacterial Pneumonia (CABP) A Clinical Study to Evaluate Pharmacokinetics, Safety and Tolerance of Single and Multiple Doses of Lefamulin in Chinese Healthy Subjects

Clinical Trial Details
SNV001(Lefamulin) Community-Acquired Bacterial Pneumonia (CABP) A Clinical Study to Compare the Efficacy and Safety of Lefamulin Versus Moxifloxacin in Chinese Adults with Community-Acquired Bacterial Pneumonia

Clinical Trial Details
SNV002(Derazantinib) Intrahepatic Cholangiocarcinoma (iCCA) A Clinical Study to Evaluate Safety and Efficacy of ARQ 087 in Chinese Inoperable, Recurrent or Metastatic Intrahepatic Cholangiocarcinoma Subjects with Advanced Solid Tumors and FGFR2 Gene Fusion Positive Who Failed at Least First-Line Systemic Therapy

Clinical Trial Details